Business Context and Reporting Period
Quince Therapeutics, Inc. (QNCX) filed this Form 8-K on March 16, 2026, reporting receipt of notices from Nasdaq regarding potential delisting. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market.
Key Financial Metrics and Listing Status
This filing does not contain financial statements, revenue, profit, cash flow, or debt metrics. The report focuses exclusively on compliance with Nasdaq listing standards:
- Minimum Bid Price: The closing bid price closed below $1.00 per share for 30 consecutive business days.
- Market Value of Listed Securities (MVLS): The MVLS was less than $50,000,000 for 30 consecutive business days.
- Compliance Deadline: The Company has 180 calendar days, until September 14, 2026, to regain compliance for both requirements.
Material Changes and Regulatory Actions
On March 16, 2026, the Company received a "Bid Price Notice" citing failure to meet Listing Rule 5450(a)(1). On March 17, 2026, the Company received an "MVLS Notice" citing failure to meet Listing Rule 5450(b)(2)(A). These notices indicate a failure to satisfy continued listing rules but do not result in immediate delisting. Trading will continue uninterrupted under the symbol "QNCX."
Outlook, Risks, and Management Commentary
Management intends to actively monitor the closing bid price and MVLS and will consider available options to resolve the deficiencies. Potential actions to regain compliance include:
- Maintaining a closing bid price of $1.00 or more for ten consecutive business days.
- Maintaining an MVLS of $50,000,000 or more for ten consecutive business days.
- Transferring the listing to the Nasdaq Capital Market, which may require a reverse stock split and payment of an application fee.
Risks: There is no assurance the Company will regain compliance. If the Company fails to comply by the September 14, 2026 deadline and is ineligible for an additional period, the stock may be delisted. An appeal to a Nasdaq Listing Qualifications Panel is possible but not guaranteed to succeed.
Investor Verification Checklist
- Verify the current closing bid price of QNCX stock to assess proximity to the $1.00 threshold.
- Monitor the Company's Market Value of Listed Securities (MVLS) against the $50,000,000 requirement.
- Watch for announcements regarding a potential reverse stock split or transfer to the Nasdaq Capital Market.
- Confirm the Company's cash position in subsequent filings (e.g., 10-Q or 10-K) to evaluate its ability to fund operations while addressing listing issues.